BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6605298)

  • 1. Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.
    Colombo MP; Pierotti MA; Ballinari D; Parmiani G
    Immunobiology; 1983 Aug; 165(2):186-99. PubMed ID: 6605298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
    Milisauskas VK; Nakamura I
    J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo immune selection of a Moloney murine leukemia virus-induced tumor results in the loss of viral- but not tumor-associated antigens.
    Jiang D; Flyer DC
    J Immunol; 1990 Nov; 145(10):3502-6. PubMed ID: 1700012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glycosylation prevents H-2K and D antigen expression on SV40 virus-transformed cells.
    Swaminathan S; Gooding LR
    Eur J Immunol; 1983 Apr; 13(4):335-40. PubMed ID: 6303796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serologic comparison of Moloney lymphoma cell surface and Moloney oncornavirus antigens.
    Humphrey D; Tsukamoto-Adey A; Witte OM; Fox R; Jerabek L; Weissman IL
    J Immunol; 1979 Jul; 123(1):412-8. PubMed ID: 87479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D; Flyer DC
    J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.